Issuer Free Writing Prospectus
Filed pursuant to Rule 433
Registration No. 333-225266
June 22, 2018
Uxin Limited, or the Company, has filed a registration statement on Form F-1, including a prospectus, with the Securities and Exchange Commission, or the SEC, for the offering to which this free writing prospectus relates. Before you invest, you should read the prospectus in that registration statement and other documents the Company has filed with the SEC for more complete information about the Company and this offering. Investors should rely upon the prospectus and any relevant free writing prospectus for complete details of this offering. You may get these documents and other documents the Company has filed for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, the Company, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling Morgan Stanley & Co. International plc toll-free at 1-866-718-1649, Goldman Sachs & Co. LLC. toll-free at 1-866-471-2526, J.P. Morgan Securities LLC toll-free at 1-866-803-9204 (calling these numbers is not toll-free outside the United States),China International Capital Corporation Hong Kong Securities Limited at 1-646-794-8800 and China Renaissance Securities (Hong Kong) Limited at 852-2287-1600. You may also access the Company's most recent prospectus dated June 22, 2018, which is included in Amendment No. 3 to the Company's registration statement on Form F-1, as filed with the SEC via EDGAR on June 22, 2018, or Amendment No. 3, by visiting EDGAR on the SEC website at https://www.sec.gov/Archives/edgar/data/1729173/000104746918004702/a2236020zf-1a.htm
The following information supplements and updates the information contained in the Company's preliminary prospectus dated June 13, 2018. All references to page numbers are to page numbers in the preliminary prospectus.
Both the CNCB Note and the GF Note will become due and payable on the 363rd day ("Maturity Date") starting from the closing date of the respective Notes, which is expected to be the same date when this offering is completed, unless earlier converted. The CNCB Note and the GF Note each bears an interest rate of 6% and 6.5%, respectively, payable until the Maturity Date or such other times as the Notes are earlier repaid or redeemed; provided that if any portion of the Notes are duly converted into Class A ordinary shares pursuant to the terms of the Notes, no interest accrued on the principal amount being converted shall be payable.
The pro forma row reflects (i) the automatic conversion of all of our issued and outstanding preferred shares into 755,082,770 Class A ordinary shares on a one-for-one basis and as such the derivative liabilities related to the bifurcated conversion features of our preferred shares, in the amount of RMB1,817.2 million (US$289.0 million) as of March 31, 2018, will automatically become shareholders' equity upon completion of this offering; (ii) the issuance of 10,203,692 Class A ordinary shares upon the conversion of Fairlubo shares held by certain Fairlubo shareholders upon completion of this offering, assuming the initial public offering price of US$11.50 per ADS, which is the midpoint of the estimated range of the initial public offering price shown on the front cover of this prospectus, see "Description of Share CapitalSecurities of Fairlubo Auction Company Limited that are convertible into securities of Uxin Limited", and the derivative liabilities amounting to RMB170.2 million (US$27.1 million) as of March 31, 2018, in relation to the share swap and redemption features of the redeemable non-controlling interests will become shareholders' equity; (iii) the grant of 17,742,890 restricted shares to Xin Gao Group Limited on May 14, 2018, which shall
become vested upon completion of this offering; (iv) the surrender of 30,964,990 shares by Xin Gao Group Limited for the repayment of outstanding loans owed to us as at March 31, 2018 and settled on May 28, 2018, assuming the initial public offering price of US$11.50 per ADS, which is the midpoint of the estimated range of the initial public offering price shown on the front cover of this prospectus.
|
As of December 31, | As of March 31, |
As of March 31, |
As of March 31, |
||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2016 | 2017 | 2018 | 2018 | 2018 | |||||||||||||||||||||||
|
RMB |
RMB |
US$ |
RMB |
US$ |
RMB |
US$ |
RMB |
US$ |
|||||||||||||||||||
|
(in thousands, except for share number) |
|||||||||||||||||||||||||||
|
Actual |
Actual |
Actual |
Pro forma(1) |
Pro forma as adjusted(2)(3) |
|||||||||||||||||||||||
Summary Consolidated Balance Sheets Data: |
||||||||||||||||||||||||||||
Cash and cash equivalents |
332,259 | 291,973 | 44,684 | 1,219,755 | 193,978 | 1,219,755 | 193,978 | 4,838,747 | 769,509 | |||||||||||||||||||
Restricted cash |
705,854 | 1,617,230 | 247,502 | 1,840,730 | 292,732 | 1,840,730 | 292,732 | 1,840,730 | 292,732 | |||||||||||||||||||
Advance to sellers |
45,774 | 246,287 | 37,692 | 251,000 | 39,917 | 251,000 | 39,917 | 251,000 | 39,917 | |||||||||||||||||||
Financial lease receivables, net |
413,462 | 438,693 | 67,138 | 342,063 | 54,398 | 342,063 | 54,398 | 342,063 | 54,398 | |||||||||||||||||||
Total assets |
2,317,979 | 5,298,913 | 810,951 | 6,562,772 | 1,043,680 | 5,915,865 | 940,801 | 9,534,857 | 1,516,332 | |||||||||||||||||||
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Convertible notes |
| | | | | | | 1,088,627 | 173,125 | |||||||||||||||||||
Short-term borrowings |
204,068 | 426,783 | 65,315 | 498,448 | 79,268 | 498,448 | 79,268 | 498,448 | 79,268 | |||||||||||||||||||
Guarantee liabilities |
76,325 | 173,907 | 26,615 | 191,290 | 30,421 | 191,290 | 30,421 | 191,290 | 30,421 | |||||||||||||||||||
Derivative liabilities |
654,511 | 1,596,424 | 244,319 | 1,987,356 | 316,050 | | | | | |||||||||||||||||||
Total liabilities |
1,986,194 | 5,059,894 | 774,372 | 5,627,159 | 894,889 | 3,639,803 | 578,839 | 4,728,430 | 751,964 | |||||||||||||||||||
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total Mezzanine equity |
4,775,637 | 8,420,644 | 1,288,703 | 10,644,521 | 1,692,804 | | | | | |||||||||||||||||||
Total shareholders' (deficit)/equity |
(4,443,852 | ) | (8,181,625 | ) | (1,252,124 | ) | (9,708,908 | ) | (1,544,013 | ) | 2,276,062 | 361,962 | 4,806,427 | 764,368 | ||||||||||||||
Number of outstanding ordinary shares |
49,318,860 | 49,318,860 | 49,318,860 | 49,318,860 | 49,318,860 | 801,383,222 | 801,383,222 | 920,383,222 | 920,383,222 |
2
derivative liabilities related to the bifurcated conversion features of our preferred shares, in the amount of RMB1,817.2 million (US$289.0 million) as of March 31, 2018, will automatically become shareholders' equity upon completion of this offering, (ii) the issuance of 10,203,692 Class A ordinary shares upon the conversion of Fairlubo shares held by certain Fairlubo shareholders upon completion of this offering, assuming the initial public offering price of US$11.50 per ADS, which is the midpoint of the estimated range of the initial public offering price shown on the front cover of this prospectus, see "Description of Share CapitalSecurities of Fairlubo Auction Company Limited that are convertible into securities of Uxin Limited", and the derivative liabilities amounting to RMB170.2 million (US$27.1 million) as of March 31, 2018, in relation to the share swap and redemption features of the redeemable non-controlling interests will become shareholders' equity; (iii) the grant of 17,742,890 restricted shares to Xin Gao Group Limited on May 14, 2018, which shall become vested upon completion of this offering, and (iv) the surrender of 30,964,990 shares by Xin Gao Group Limited for the repayment of outstanding loans owed to us as at March 31, 2018 and settled on May 28, 2018, assuming the initial public offering price of US$11.50 per ADS, which is the midpoint of the estimated range of the initial public offering price shown on the front cover of this prospectus.
3
|
As of March 31, 2018 (unaudited) | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Actual | Pro Forma | Pro Forma As Adjusted(1) |
||||||||||||||||
|
(in thousands) |
||||||||||||||||||
|
RMB |
US$ |
RMB |
US$ |
RMB |
US$ |
|||||||||||||
Debt: |
|||||||||||||||||||
Convertible notes |
| | | | 1,088,627 | 173,125 | |||||||||||||
Current portion of long-term borrowings |
173,561 | 27,602 | 173,561 | 27,602 | 173,561 | 27,602 | |||||||||||||
Long-term borrowings |
518,485 | 82,455 | 518,485 | 82,455 | 518,485 | 82,455 | |||||||||||||
Mezzanine Equity: |
|||||||||||||||||||
Series A convertible redeemable preferred shares (US$0.0001 par value, 50,000,000 shares authorized, issued and outstanding on an actual basis, nil outstanding on a pro forma and pro forma as adjusted basis) |
96,011 | 15,269 | | | | | |||||||||||||
Series A-1 convertible redeemable preferred shares (US$0.0001 par value, 4,910,890 shares authorized, issued and outstanding on an actual basis, nil outstanding on a pro forma and pro forma as adjusted basis) |
70,839 | 11,266 | | | | | |||||||||||||
Series B convertible redeemable preferred shares (US$0.0001 par value, 70,602,630 shares authorized, issued and outstanding on an actual basis, nil outstanding on a pro forma and pro forma as adjusted basis) |
183,397 | 29,166 | | | | | |||||||||||||
Series C convertible redeemable preferred shares (US$0.0001 par value, 97,267,680 shares authorized, issued and outstanding on an actual basis, and nil outstanding on a pro forma and pro forma as adjusted basis) |
416,783 | 66,281 | | | | | |||||||||||||
Series D convertible redeemable preferred shares (US$0.0001 par value, 159,355,150 shares authorized, issued and outstanding on an actual basis, and nil outstanding on a pro forma and pro forma as adjusted basis) |
1,739,580 | 276,646 | | | | | |||||||||||||
Series E convertible redeemable preferred shares (US$0.0001 par value, 89,477,490 shares authorized, issued and outstanding on an actual basis, and nil outstanding on a pro forma and pro forma as adjusted basis) |
1,169,434 | 185,976 | | | | | |||||||||||||
Series F convertible redeemable preferred shares (US$0.0001 par value, 85,162,200 shares authorized, issued and outstanding on an actual basis, and nil outstanding on a pro forma and pro forma as adjusted basis) |
1,596,159 | 253,838 | | | | | |||||||||||||
Series G convertible redeemable preferred shares (US$0.0001 par value, nil and 130,384,730 shares authorized, issued and outstanding on an actual basis, and nil outstanding on a pro forma and pro forma as adjusted basis) |
3,248,711 | 516,644 | | | | | |||||||||||||
Series G-Plus convertible redeemable preferred shares (US$0.0001 par value, nil and 67,922,000 shares authorized, issued and outstanding on an actual basis, nil outstanding on a pro forma and pro forma as adjusted basis) |
2,084,027 | 331,424 | | | | | |||||||||||||
Redeemable non-controlling interest |
39,580 | 6,294 | |||||||||||||||||
| | | | | | | | | | | | | | | | | | | |
Total mezzanine equity |
10,644,521 | 1,692,804 | | | | | |||||||||||||
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
4
|
As of March 31, 2018 (unaudited) | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Actual | Pro Forma | Pro Forma As Adjusted(1) |
||||||||||||||||
|
(in thousands) |
||||||||||||||||||
|
RMB |
US$ |
RMB |
US$ |
RMB |
US$ |
|||||||||||||
Shareholders' (deficit)/equity: |
|||||||||||||||||||
Ordinary shares, (US$0.0001 par value; 1,244,917,230 shares authorized, 49,318,860 shares authorized issued and outstanding on an actual basis; 753,547,502 Class A and 47,835,720 Class B shares issued and outstanding on a pro forma basis; and 872,547,502 Class A and 47,835,720 Class B shares issued and outstanding on a pro forma as adjusted basis) |
30 | 5 | 504 | 80 | 578 | 91 | |||||||||||||
Additional paid-in capital(2) |
| | 12,574,127 | 1,999,669 | 15,134,681 | 2,406,878 | |||||||||||||
Accumulated other comprehensive income |
88,763 | 14,116 | 88,763 | 14,116 | 88,763 | 14,116 | |||||||||||||
Accumulated deficit |
(9,739,485 | ) | (1,548,876 | ) | (10,329,116 | ) | (1,642,645 | ) | (10,359,379 | ) | (1,647,459 | ) | |||||||
| | | | | | | | | | | | | | | | | | | |
Total UXIN LIMITED shareholders' (deficit)/equity |
(9,650,692 | ) | (1,534,755 | ) | 2,334,278 | 371,220 | 4,864,643 | 773,626 | |||||||||||
Non-controlling interests |
(58,216 | ) | (9,258 | ) | (58,216 | ) | (9,258 | ) | (58,216 | ) | (9,258 | ) | |||||||
| | | | | | | | | | | | | | | | | | | |
Total shareholders' (deficit)/equity(2) |
(9,708,908 | ) | (1,544,013 | ) | 2,276,062 | 361,962 | 4,806,427 | 764,368 | |||||||||||
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Total mezzanine equity and total shareholders' (deficit)/equity |
935,613 | 148,791 | 2,276,062 | 361,962 | 4,806,427 | 764,368 | |||||||||||||
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Total capitalization |
1,627,659 | 258,848 | 2,968,108 | 472,019 | 6,587,100 | 1,047,550 | |||||||||||||
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Our net tangible book value as of March 31, 2018 was approximately US$132.59 million, or US$2.69 per ordinary share as of that date and US$8.07 per ADS. Net tangible book value represents the amount of our total consolidated tangible assets, less the amount of our total consolidated liabilities. Pro forma net tangible book value per ordinary share represents our net tangible book value divided by our total number of outstanding ordinary shares, each after giving effect to (i) the automatic conversion of all of our issued and outstanding preferred shares into 755,082,770 Class A ordinary shares on a one-for-one basis and as such the derivative liabilities related to the bifurcated conversion features of our preferred shares, in the amount of RMB1,817.2 million (US$289.0 million) as of March 31, 2018, will automatically become shareholders' equity upon completion of this offering, (ii) the issuance of 10,203,692 Class A ordinary shares upon the conversion of Fairlubo shares held by certain Fairlubo shareholders upon completion of this offering, assuming the initial public offering price of US$11.50 per ADS, which is the midpoint of the estimated range of the initial public offering price shown on the front cover of this prospectus, see "Description of Share CapitalSecurities of Fairlubo Auction Company Limited that are convertible into securities of Uxin Limited," and the derivative liabilities amounting to RMB170.2 million (US$27.1 million) as of March 31, 2018, in relation to the share swap and redemption features of the redeemable non-controlling interests will become shareholders' equity; (iii) the grant of 17,742,890 restricted shares to Xin Gao Group Limited on May 14, 2018, which shall become vested upon completion of this offering, (iv) the surrender of 30,964,990 shares by Xin Gao Group Limited for the repayment of outstanding loans owed to us as at March 31, 2018 and settled on May 28, 2018, assuming the initial public offering price of US$11.50 per ADS, which is the midpoint of the estimated range of the initial public offering price shown on the front cover of this prospectus. Because the Class A ordinary shares and Class B ordinary shares have the same dividend and other rights, except for voting and conversion rights, the dilution is presented based on all ordinary shares, including Class A ordinary shares and Class B ordinary shares.
Without taking into account any other changes in net tangible book value after March 31, 2018, other than to give effect to (i) the automatic conversion of all of our issued and outstanding preferred shares into 755,082,770 Class A ordinary shares on a one-for-one basis and as such the derivative liabilities related to the bifurcated conversion features of our preferred shares, in the amount of RMB1,817.2 million (US$289.0 million) as of March 31, 2018, will automatically become shareholders'
5
equity upon completion of this offering, (ii) the issuance of 10,203,692 Class A ordinary shares upon the conversion of Fairlubo shares held by certain Fairlubo shareholders upon completion of this offering, assuming the initial public offering price of US$11.50 per ADS, which is the midpoint of the estimated range of the initial public offering price shown on the front cover of this prospectus, and the derivative liabilities amounting to RMB170.2 million (US$27.1 million) as of March 31, 2018, in relation to the share swap and redemption features of the redeemable non-controlling interests will become shareholders' equity; (iii) the grant of 17,742,890 restricted shares to Xin Gao Group Limited on May 14, 2018, which shall become vested upon completion of this offering, (iv) the surrender of 30,964,990 shares by Xin Gao Group Limited for the repayment of outstanding loans owed to us as at March 31, 2018 and settled on May 28, 2018, assuming the initial public offering price of US$11.50 per ADS, which is the midpoint of the estimated range of the initial public offering price shown on the front cover of this prospectus, (v) the exercise of vested stock options (including accelerated vesting to certain stock options) by one of the Company's executive officers to acquire total 5,000,000 ordinary shares of the Company on May 25, 2018, and (vi) the sale of 114,000,000 Class A ordinary shares in the form of ADSs by us in this offering at an assumed initial public offering price of US$11.50 per ADS, which is the midpoint of the estimated range of the initial public offering price shown on the front cover of this prospectus, after deducting the underwriting discounts and commissions and estimated offering expenses payable by us, assuming the underwriters do not exercise over-allotment option, our pro forma as adjusted net tangible book value as of March 31, 2018 would have been US$748.17 million, or US$0.81 per ordinary share and US$ 2.43 per ADS. This represents an immediate decrease in net tangible book value of US$1.88 per ordinary share and US$5.64 per ADS to the existing shareholders and an immediate dilution in net tangible book value of US$3.02 per ordinary share and US$9.07 per ADS to investors purchasing ADSs in this offering. The following table illustrates such dilution:
The pro forma as adjusted information does not include the impact of the issuance of convertible notes to certain third party investors, which shall be consummated concurrently with the closing of this offering. The investors may elect to convert their respective convertible notes into Class A ordinary shares from the 181st day after the date of this prospectus, see "Prospectus SummaryThe Offering."
The deposit agreement among us, the depositary, ADS holders and other parties thereto is not one of our constituent documents.
|
As of December 31, | As of March 31, | As of March 31, | As of March 31, | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2016 | 2017 | 2018 | 2018 | 2018 | |||||||||||||||||||||||
|
RMB |
RMB |
US$ |
RMB |
US$ |
RMB |
US$ |
RMB |
US$ |
|||||||||||||||||||
|
(in thousands, except for share data) |
|||||||||||||||||||||||||||
|
Actual |
Actual |
Actual |
Pro forma |
Pro forma as adjusted |
|||||||||||||||||||||||
Selected Consolidated Balance Sheets Data: |
||||||||||||||||||||||||||||
Cash and cash equivalents |
332,259 | 291,973 | 44,684 | 1,219,755 | 193,978 | 1,219,755 | 193,978 | 4,838,747 | 769,509 | |||||||||||||||||||
Restricted cash |
705,854 | 1,617,230 | 247,502 | 1,840,730 | 292,732 | 1,840,730 | 292,732 | 1,840,730 | 292,732 | |||||||||||||||||||
Advance to sellers |
45,774 | 246,287 | 37,692 | 251,000 | 39,917 | 251,000 | 39,917 | 251,000 | 39,917 | |||||||||||||||||||
Financial lease receivables, net |
413,462 | 438,693 | 67,138 | 342,063 | 54,398 | 342,063 | 54,398 | 342,063 | 54,398 | |||||||||||||||||||
Total assets |
2,317,979 | 5,298,913 | 810,951 | 6,562,772 | 1,043,680 | 5,915,865 | 940,801 | 9,534,857 | 1,516,332 | |||||||||||||||||||
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Convertible notes |
| | | | | | | 1,088,627 | 173,125 | |||||||||||||||||||
Short-term borrowings |
204,068 | 426,783 | 65,315 | 498,448 | 79,268 | 498,448 | 79,268 | 498,448 | 79,268 | |||||||||||||||||||
Guarantee liabilities |
76,325 | 173,907 | 26,615 | 191,290 | 30,421 | 191,290 | 30,421 | 191,290 | 30,421 | |||||||||||||||||||
Derivative liabilities |
654,511 | 1,596,424 | 244,319 | 1,987,356 | 316,050 | | | | | |||||||||||||||||||
Total liabilities |
1,986,194 | 5,059,894 | 774,372 | 5,627,159 | 894,889 | 3,639,803 | 578,839 | 4,728,430 | 751,964 | |||||||||||||||||||
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Total Mezzanine equity |
4,775,637 | 8,420,644 | 1,288,703 | 10,644,521 | 1,692,804 | | | | | |||||||||||||||||||
Total shareholders' deficit |
(4,443,852 | ) | (8,181,625 | ) | (1,252,124 | ) | (9,708,908 | ) | (1,544,013 | ) | 2,276,062 | 361,962 | 4,806,427 | 764,368 | ||||||||||||||
Number of outstanding ordinary shares |
49,318,860 | 49,318,860 | 49,318,860 | 49,318,860 | 49,318,860 | 801,383,222 | 801,383,222 | 920,383,222 | 920,383,222 |
6
A total of 98,429,570 ordinary shares on an as-converted basis are attributable to Mr. Kun Dai through his ownership interests in Xin Gao Group Limited, Gao Li Group Limited, Kingkey New Era Auto Industry Limited, Kingkey New Era Auto Industry Global Limited and BOCOM International Supreme Investment Limited, representing approximately 12.4% of our total ordinary shares on an as-converted basis as of the date of this prospectus.
Prior to the completion of this offering, shares of Uxin Limited accounting for 2.2%, 7.2%, 7.7%, and 1.9% of outstanding ordinary shares of Uxin Limited on an as-converted basis beneficially owned by Mr. Kun Dai through Gao Li Group Limited, Kingkey New Era Auto Industry Limited, Kingkey New Era Auto Industry Global Limited and BOCOM International Supreme Investment Limited, respectively, have been pledged to independent third parties.
A total of 71,032,978 ordinary shares on an as-converted basis are attributable to the Jeneration Capital Affiliated Entities through their direct ownership interests in our shares and their ownership interests in Kingkey New Era Auto Industry Limited, Kingkey New Era Auto Industry Global Limited and BOCOM International Supreme Investment Limited, representing approximately 8.9% of our total ordinary shares on an as-converted basis as of the date of this prospectus.
The deposit agreement gives the depositary or an ADS holder asserting a claim against us the right to require us to submit that claim to binding arbitration in New York under the Rules of the American Arbitration Association, including any United Stated federal securities law claim. However, a claimant could also elect not to submit its claim to arbitration and instead bring its claim in any court having jurisdiction of it. The deposit agreement does not give us the right to require anyone to submit any claim to arbitration.
Notwithstanding the restrictions described in the preceding paragraph, certain of our shareholders, including Mr. Kun Dai, our chairman and chief executive officer, have pledged shares that represent 18.9% of our pre-offering share capital (or 16.3% of our post-offering share capital assuming the underwriters do not exercise over-allotment option) in favor of third party lenders in connection with certain loan agreements entered into in 2017 with a term of two years, most proceeds of which were used to fund the purchase of shares in the Company in the latest rounds of pre-IPO equity financings. See "Principal Shareholders," footnote (1). If any lender enforces its security interests in such pledged shares upon an event of default, the pledged shares can be sold without regard to the lock-up restrictions. The loan agreements do not have margin call requirements or top-up obligations regarding our shares.
7
|
Notes | As of December 31, 2017 |
As of March 31, 2018 |
Pro forma as of March 31, 2018 |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
RMB |
RMB |
US$ |
RMB |
US$ |
||||||||||||
ASSETS |
||||||||||||||||||
Current assets: |
||||||||||||||||||
Cash and cash equivalents |
2.6 | 291,973 | 1,219,755 | 193,978 | 1,219,755 | 193,978 | ||||||||||||
Restricted cash |
2.7 | 1,617,230 | 1,840,730 | 292,732 | 1,840,730 | 292,732 | ||||||||||||
Short-term investments |
2.7 | 1,000 | 10,000 | 1,590 | 10,000 | 1,590 | ||||||||||||
Accounts receivable |
40,155 | 44,350 | 7,054 | 44,350 | 7,054 | |||||||||||||
Amounts due from related parties |
20, 31 | 608,291 | 647,484 | 102,970 | 577 | 91 | ||||||||||||
Advance to consumers on behalf of financing partners |
4 | 827,417 | 507,392 | 80,691 | 507,392 | 80,691 | ||||||||||||
Loan recognized as a result of payment under the guarantee, net |
5 | 252,555 | 411,985 | 65,518 | 411,985 | 65,518 | ||||||||||||
Advance to sellers |
6 | 246,287 | 251,000 | 39,917 | 251,000 | 39,917 | ||||||||||||
Other receivables, net |
7 | 251,649 | 335,793 | 53,401 | 335,793 | 53,401 | ||||||||||||
Inventory |
2.8 | 77,941 | 44,470 | 7,072 | 44,470 | 7,072 | ||||||||||||
Prepaid expenses and other current assets |
8 | 249,769 | 493,673 | 78,509 | 493,673 | 78,509 | ||||||||||||
Financial lease receivables, net |
9 | 438,693 | 342,063 | 54,398 | 342,063 | 54,398 | ||||||||||||
| | | | | | | | | | | | | | | | | | |
Total current assets |
4,902,960 | 6,148,695 | 977,830 | 5,501,788 | 874,951 | |||||||||||||
| | | | | | | | | | | | | | | | | | |
Non-current assets: |
||||||||||||||||||
Property, equipment and software, net |
10 | 156,625 | 177,142 | 28,171 | 177,142 | 28,171 | ||||||||||||
Intangible assets, net |
11 | 9,949 | 9,032 | 1,436 | 9,032 | 1,436 | ||||||||||||
Goodwill |
2.15 | 75,849 | 75,849 | 12,062 | 75,849 | 12,062 | ||||||||||||
Long-term investments |
12 | 40,628 | 39,152 | 6,226 | 39,152 | 6,226 | ||||||||||||
Other non-current assets |
13 | 112,902 | 112,902 | 17,955 | 112,902 | 17,955 | ||||||||||||
| | | | | | | | | | | | | | | | | | |
Total non-current assets |
395,953 | 414,077 | 65,850 | 414,077 | 65,850 | |||||||||||||
| | | | | | | | | | | | | | | | | | |
Total assets |
5,298,913 | 6,562,772 | 1,043,680 | 5,915,865 | 940,801 | |||||||||||||
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
LIABILITIES AND EQUITY |
||||||||||||||||||
Current liabilities (including amounts of the consolidated VIEs and VIEs' subsidiaries without recourse to the primary beneficiary of RMB407,809 and RMB263,461 as of December 31, 2017 and March 31, 2018, respectively) |
|
|||||||||||||||||
Short-term borrowings |
14 | 426,783 | 498,448 | 79,268 | 498,448 | 79,268 | ||||||||||||
Accounts payable |
65,694 | 41,440 | 6,590 | 41,440 | 6,590 | |||||||||||||
Guarantee liabilities |
15 | 173,907 | 191,290 | 30,421 | 191,290 | 30,421 | ||||||||||||
Deposit of interests from consumers and payable to financing partnerscurrent |
16 | 732,273 | 902,009 | 143,447 | 902,009 | 143,447 | ||||||||||||
Advance from buyers collected on behalf of sellers |
17 | 226,891 | 184,397 | 29,325 | 184,397 | 29,325 | ||||||||||||
Other payables and accruals |
18 | 927,389 | 868,225 | 138,074 | 868,225 | 138,074 | ||||||||||||
Deferred revenue |
2.18 | 27,598 | 29,259 | 4,653 | 29,259 | 4,653 | ||||||||||||
Other current liabilities |
19 | 163,355 | | | | | ||||||||||||
Derivative liabilities |
3, 23 | 1,596,424 | 1,987,356 | 316,050 | | | ||||||||||||
| | | | | | | | | | | | | | | | | | |
Total current liabilities |
4,340,314 | 4,702,424 | 747,828 | 2,715,068 | 431,778 | |||||||||||||
| | | | | | | | | | | | | | | | | | |
Non-current liabilities |
||||||||||||||||||
Long-term borrowings |
14 | 374,104 | 518,485 | 82,455 | 518,485 | 82,455 | ||||||||||||
Deposit of interests from consumers and payable to financing partnersnon-current |
16 | 343,823 | 404,752 | 64,368 | 404,752 | 64,368 | ||||||||||||
Deferred tax liabilities |
21 | 1,653 | 1,498 | 238 | 1,498 | 238 | ||||||||||||
| | | | | | | | | | | | | | | | | | |
Total non-current liabilities |
719,580 | 924,735 | 147,061 | 924,735 | 147,061 | |||||||||||||
| | | | | | | | | | | | | | | | | | |
Total liabilities |
5,059,894 | 5,627,159 | 894,889 | 3,639,803 | 578,839 | |||||||||||||
| | | | | | | | | | | | | | | | | | |
Commitments and contingencies |
29 | |||||||||||||||||
Mezzanine equity |
23 |
|||||||||||||||||
Series A convertible redeemable preferred shares (US$0.0001 par value, 50,000,000 shares authorized, issued and outstanding as of December 31, 2017 and March 31, 2018, respectively, nil outstanding on a pro-forma basis as of March 31, 2018 (unaudited)) |
94,411 |
96,011 |
15,269 |
|
|
8
|
Notes | As of December 31, 2017 |
As of March 31, 2018 |
Pro forma as of March 31, 2018 |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
RMB |
RMB |
US$ |
RMB |
US$ |
||||||||||||
Mezzanine equity (Continued) |
||||||||||||||||||
Series A-1 convertible redeemable preferred shares (US$0.0001 par value, 4,910,890 shares authorized, issued and outstanding as of December 31, 2017 and March 31, 2018, respectively, nil outstanding on a pro-forma basis as of March 31, 2018 (unaudited)) |
69,193 | 70,839 | 11,266 | | | |||||||||||||
Series B convertible redeemable preferred shares (US$0.0001 par value, 70,602,630 shares authorized, issued and outstanding as of December 31, 2017 and March 31, 2018, respectively, and nil outstanding on a pro-forma basis as of March 31, 2018 (unaudited)) |
180,294 | 183,397 | 29,166 | | | |||||||||||||
Series C convertible redeemable preferred shares (US$0.0001 par value, 97,267,680 shares authorized, issued and outstanding as of December 31, 2017 and March 31, 2018, respectively, and nil outstanding on a pro-forma basis as of March 31, 2018 (unaudited)) |
408,559 | 416,783 | 66,281 | | | |||||||||||||
Series D convertible redeemable preferred shares (US$0.0001 par value, 159,355,150 shares authorized, issued and outstanding as of December 31, 2017 and March 31, 2018, respectively, and nil outstanding on a pro-forma basis as of Mach 31, 2018 (unaudited)) |
1,703,667 | 1,739,580 | 276,646 | | | |||||||||||||
Series E convertible redeemable preferred shares (US$0.0001 par value, 89,477,490 shares authorized, issued and outstanding as of December 31, 2017 and March 31, 2018, respectively, and nil outstanding on a pro-forma basis as of Mach 31, 2018 (unaudited)) |
1,146,351 | 1,169,434 | 185,976 | | | |||||||||||||
Series F convertible redeemable preferred shares (US$0.0001 par value, 85,162,200 shares authorized, issued and outstanding as of December 31, 2017 and March 31, 2018, respectively, and nil outstanding on a pro-forma basis as of Mach 31, 2018 (unaudited)) |
1,563,657 | 1,596,159 | 253,838 | | | |||||||||||||
Series G convertible redeemable preferred shares (US$0.0001 par value, 130,384,730 shares authorized, issued and outstanding as of December 31 2017 and March 31, 2018, and nil outstanding on a pro-forma basis as of March 31, 2018 (unaudited)) |
3,214,932 | 3,248,711 | 516,644 | | | |||||||||||||
Series G-Plus convertible redeemable preferred shares (US$0.0001 par value, nil and 67,922,000 shares authorized, issued and outstanding as of December 31 2017 and March 31, 2018, and nil outstanding on a pro-forma basis as of March 31, 2018 (unaudited)) |
| 2,084,027 | 331,424 | | | |||||||||||||
Redeemable non-controlling interests |
3 |
39,580 |
39,580 |
6,294 |
|
|
||||||||||||
| | | | | | | | | | | | | | | | | | |
Total Mezzanine equity |
8,420,644 | 10,644,521 | 1,692,804 | | | |||||||||||||
| | | | | | | | | | | | | | | | | | |
Shareholders' (deficit)/equity |
||||||||||||||||||
Ordinary shares (US$0.0001 par value, 1,312,839,230 and 1,244,917,230 shares authorized as of December 31, 2017 and March 31, 2018, respectively, 49,318,860 shares authorized, issued and outstanding as of December 31, 2017 and March 31, 2018, respectively, and 753,547,502 Class A and 47,835,720 Class B shares outstanding on a pro forma basis as of March 31, 2018(unaudited)) |
22, 31 | 30 | 30 | 5 | 504 | 80 | ||||||||||||
Additional paid-in capital |
| | | 12,574,127 | 1,999,669 | |||||||||||||
Accumulated other comprehensive income |
76,607 | 88,763 | 14,116 | 88,763 | 14,116 | |||||||||||||
Accumulated deficit |
(8,207,801 | ) | (9,739,485 | ) | (1,548,876 | ) | (10,329,116 | ) | (1,642,645 | ) | ||||||||
| | | | | | | | | | | | | | | | | | |
Total UXIN LIMITED shareholders' (deficit)/equity |
(8,131,164 | ) | (9,650,692 | ) | (1,534,755 | ) | 2,334,278 | 371,220 | ||||||||||
Non-controlling interests |
(50,461 | ) | (58,216 | ) | (9,258 | ) | (58,216 | ) | (9,258 | ) | ||||||||
| | | | | | | | | | | | | | | | | | |
Total shareholders' (deficit)/equity |
(8,181,625 | ) | (9,708,908 | ) | (1,544,013 | ) | 2,276,062 | 361,962 | ||||||||||
| | | | | | | | | | | | | | | | | | |
Total liabilities, mezzanine equity and shareholders' deficit |
5,298,913 | 6,562,772 | 1,043,680 | 5,915,865 | 940,801 | |||||||||||||
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
CNCB (Hong Kong) and Golden Fortune may elect to convert their respective Notes into Class A ordinary shares from the 181st day after the date of this prospectus with conversion price per ordinary shares equal to 109.5% and 108% of the initial public offering price per ordinary share, respectively.
Upon the completion of a qualified initial public offering, the Series A, A-1, B, C, D, E, F, G and G-Plus Preferred Shares shall automatically be converted into Class A ordinary shares, and as such the derivative liabilities related to the bifurcated conversion features of our preferred shares will automatically become shareholders' equity.
Upon the completion of this offering, the Fairlubo shares owned by certain Fairlubo shareholders will be converted into the Class A ordinary shares and the derivative liabilities in relation to the share
9
swap and redemption features of the redeemable non-controlling interests will become shareholders' equity.
The unaudited pro-forma balance sheet as of March 31, 2018 assumes a qualified initial public offering has occurred and presents an adjusted financial position as if the conversion of all outstanding Series A, A-1, B, C, D, E, F, G and G-Plus Preferred Shares into Class A ordinary shares at the conversion ratio as described in Note 23 to the unaudited interim condensed consolidated financial statements and conversion of the Fairlubo shares into Class A ordinary shares as described in Note 31 to the unaudited interim condensed consolidated financial statements occurred on March 31, 2018.
Unaudited pro-forma basic and diluted net loss per share was computed to give effect to the automatic conversion of the Series A, A-1, B, C, D, E, F, G and G-Plus Preferred Shares using the "if converted" method as though the conversion had occurred as of the beginning of the period or the original date of issuance, if later.
In addition to these conversion effects of the Preferred Shares, the unaudited pro-forma balance sheet as of March 31, 2018 and the unaudited pro-forma basic and diluted net loss per share for the three months ended March 31, 2018 also reflect pro-forma effect of the issuance and vest of restricted shares to Xin Gao Group (Note 31(a)) as if the qualified initial public offering has occurred on March 31, 2018, the pro-forma effect of the Company's repurchase of the Surrender Shares (Note 31(b)), as well as the pro-forma effect of Fairlubo Share Swap (Note 31(d)).
|
For the three months ended March 31, 2018 |
For the three months ended March 31, 2018 |
|||||
---|---|---|---|---|---|---|---|
|
RMB |
US$ |
|||||
Numerator: |
|||||||
Net loss attributable to ordinary shareholders |
(1,534,015 | ) | (243,956 | ) | |||
Pro-forma effect of the issuance and vest of restricted shares to Xin Gao Group(1) |
(589,631 | ) | (93,769 | ) | |||
Accretion on redeemable preferred shares |
157,539 | 25,054 | |||||
Deemed dividend to preferred shareholders |
544,773 | 86,636 | |||||
Fair value loss on derivative liabilities |
359,115 | 57,110 | |||||
| | | | | | | |
Numerator for pro-forma basic and diluted net loss per share |
(1,062,219 | ) | (168,925 | ) | |||
Denominator: |
|||||||
Weighted average number of ordinary shares outstanding |
49,318,860 | 49,318,860 | |||||
Pro-forma effect of the conversion of Series A Preferred Shares |
50,000,000 | 50,000,000 | |||||
Pro-forma effect of the conversion of Series A-1 Preferred Shares |
4,910,890 | 4,910,890 | |||||
Pro-forma effect of the conversion of Series B Preferred Shares |
70,602,630 | 70,602,630 | |||||
Pro-forma effect of the conversion of Series C Preferred Shares |
97,267,680 | 97,267,680 | |||||
Pro-forma effect of the conversion of Series D Preferred Shares |
159,355,150 | 159,355,150 | |||||
Pro-forma effect of the conversion of Series E Preferred Shares |
89,477,490 | 89,477,490 | |||||
Pro-forma effect of the conversion of Series F Preferred Shares |
85,162,200 | 85,162,200 | |||||
Pro-forma effect of the conversion of Series G Preferred Shares |
130,384,730 | 130,384,730 | |||||
Pro-forma effect of the conversion of Series G-Plus Preferred Shares |
67,158,830 | 67,158,830 | |||||
Pro-forma effect of the issuance and vest of restricted shares to Xin Gao Group (Note 31(a)) |
17,742,890 | 17,742,890 | |||||
Pro-forma effect of repurchase of the Surrender Shares (Note 31(b)) |
(30,964,990 | ) | (30,964,990 | ) | |||
Pro-forma effect of Fairlubo Share Swap (Note 4)(2) |
10,203,692 | 10,203,692 | |||||
| | | | | | | |
Denominator for pro-forma basic and diluted net loss per share |
800,620,052 | 800,620,052 | |||||
Pro-forma net loss per share: |
|||||||
Basic |
(1.33 | ) | (0.21 | ) | |||
Diluted |
(1.33 | ) | (0.21 | ) |
10